News Akorn Issues Voluntary Nationwide Recall of Various Human and Animal Drug Products Within Expiry Due to Company Shutdown April 26, 2023 Read More » Vowst April 26, 2023 Read More » Qalsody April 25, 2023 Read More » FDA clarifies pharmacist recommendations in Buprenorphine for Opioid Dependence REMS April 19, 2023 Read More » Novartis Announces Positive Topline Results for Kisquali as Adjuvant Treatment for Early Breast Cancer April 19, 2023 Read More » FDA Adds Quinacrine Hydrochloride (quinacrine) to the List of Bulk Drug Substances that May Be Used in Compounding by Outsourcing Facilities (503B Bulks List) April 19, 2023 Read More » Update on Insulin Prices and Pipeline Products April 19, 2023 Read More » Ascend Laboratories LLC Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules, USP 75 mg and 150 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity April 19, 2023 Read More » Omisirge April 17, 2023 Read More » Page1 Page2 Page3 Page4 … Page30 Benefit Advisors & Employees - Want to know more? Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager Full Name(Required) Email(Required) Comment(Required) Company Name(Required) CAPTCHA
Akorn Issues Voluntary Nationwide Recall of Various Human and Animal Drug Products Within Expiry Due to Company Shutdown April 26, 2023 Read More »
FDA clarifies pharmacist recommendations in Buprenorphine for Opioid Dependence REMS April 19, 2023 Read More »
Novartis Announces Positive Topline Results for Kisquali as Adjuvant Treatment for Early Breast Cancer April 19, 2023 Read More »
FDA Adds Quinacrine Hydrochloride (quinacrine) to the List of Bulk Drug Substances that May Be Used in Compounding by Outsourcing Facilities (503B Bulks List) April 19, 2023 Read More »
Ascend Laboratories LLC Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules, USP 75 mg and 150 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity April 19, 2023 Read More »